Expression of the α7, α4 and α3 nicotinic receptor subtype in the brain and adrenal medulla of transgenic mice carrying genes coding for human AChE and β-amyloid

International Journal of Developmental Neuroscience

Volumn 24, Issue 4, 2006, Pages 269-273

  Mousavi, Malahat ^a   Nordberg, Agneta ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

3, 4, 7 nicotinic receptor; AChE; Adrenal medulla; Alzheimer's disease; APPSWE; Cerebral cortex; Transgenic mice

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; NICOTINIC RECEPTOR; PROTEIN SUBUNIT; BUNGAROTOXIN; IODINE; MESSENGER RNA;

ADRENAL MEDULLA; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; BRAIN; CONTROLLED STUDY; GENE EXPRESSION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; TRANSGENIC MOUSE; AGE; ANIMAL; CLASSIFICATION; COMPARATIVE STUDY; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; METHODOLOGY; RADIOASSAY;

MUS MUSCULUS;

ACETYLCHOLINESTERASE; ADRENAL MEDULLA; AGE FACTORS; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; BUNGAROTOXINS; GENE EXPRESSION; HUMANS; IODINE ISOTOPES; MICE; MICE, TRANSGENIC; PROTEIN BINDING; PROTEIN SUBUNITS; RADIOLIGAND ASSAY; RECEPTORS, NICOTINIC; RNA, MESSENGER;

EID: 33646830466     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2006.02.002     Document Type: Article

References (30)

1. Alvarez A., Opazo C., Alarcon R., Garrido J., and Inestrosa N.C. Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils. J. Mol. Biol. 272 (1997) 348-361
2. Bednar I., Paterson D., Marutle M., Pham T.M., Svedberg M., Hellstrom-Lindahl E., Mousavi M., Court J., Morris C., Perry E., Mohammed A., Zhang X., and Nordberg A. Selective nicotinic receptor consequences in APPSWE transgenic mice. Mol. Cell. Neurosci. 20 (2002) 354-365
3. Beeri R., Andres C., Lev-Lehman E., Timberg R., Huberman T., Shani M., and Soreq H. Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr. Biol. 5 (1995) 1063-1071
4. Beeri R., Le Novere N., Mervis R., Huberman T., Grauer E., Changeux J.P., and Soreq H. Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired acetylcholinesterase-transgenic mice. J. Neurochem. 69 (1997) 2441-2451
5. Darboux I., Barthalay Y., Piovant M., and Hipeau-Jacquotte R. The structure-function relationships in Drosophila neurotactin show that cholinesterasic domains may have adhesive properties. EMBO J. 15 (1996) 4835-4843
6. Dineley K.T., Westerman M., Bui D., Bell K., Ashe K.H., and Sweatt J.D. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: in vitro and in vivo mechanisms related to Alzheimer's disease. J. Neurosci. 21 (2001) 4125-4133
7. Geula C., Greenberg B.D., and Mesulam M.M. Cholinesterase activity in the plaques, tangles and angiopathy of Alzheimer's disease does not emanate from amyloid. Brain Res. 644 (1994) 327-330
8. Guan Z.Z., Zhang X., Ravid R., and Nordberg A. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J. Neurochem. 74 (2000) 237-243
9. Hellström-Lindahl E., Mousavi M., Zhang X., Ravid R., and Nordberg A. Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer, normal brain. Mol. Brain Res. 66 (1999) 94-103
10. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G. Correlative memory deficits, Aβeta elevation, amyloid plaques in transgenic mice. Science 274 (1996) 99-102
11. Inestrosa N.C., Alvarez A., Godoy J., Reyes A., and De Ferrari G.V. Acetylcholinesterase-amyloid-beta-peptide interaction. Wnt signaling involvement in Aβeta neurotoxicity. Acta Neurol. Scand. Suppl. 176 (2000) 53-59
12. Kilpatrick D.L., Slepetis R., and Kirshner N. Inhibition of catecholamine secretion from adrenal medulla cells by neurotoxins and cholinergic antagonists. J. Neurochem. 37 (1981) 125-131
13. Leger J.M., Moulias R., Vellas B., Monfort J.C., Chapuy P., Robert P., Knellesen S., and Gerard D. Causes and consequences of elderly's agitated and aggressive behavior. Encephale 26 (2000) 32-43
14. Lowry O.H., Rosebrough N.J., and Farr A.L. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
15. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 430 (2004) 631-639
16. Mizobe F., Kozousek V., Dean D.M., and Livett B.G. Pharmacological characterization of adrenal paraneurons: substance P and somatostatin as inhibitory modulators of the nicotinic response. Brain Res. 178 (1979) 555-566
17. Moechars D., Gilis M., Kuiperi C., Laenen I., and Van Leuven F. Aggressive behavior in transgenic mice expressing APP is alleviated by serotonergic drugs. Neuroreport 9 (1998) 3561-3564
18. Mousavi M., Bednar I., and Nordberg A. Selective changes in expression of different nicotinic receptor subtypes in brain and adrenal medulla of mice carrying human mutated gene for APP or over-expressing human acetylcholinestrase. Int. J. Dev. Neurosci. 22 (2004) 545-549
19. Mousavi M., Hellström-Lindahl E., Guan Z.Z., Bedna I., and Nordberg A. Expression of nicotinic acetylcholine receptors in human and rat adrenal medulla. Life Sci. 70 (2001) 577-590
20. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., and Lannfelt L. Pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat. Genet. 1 (1992) 345-347
21. Nagele R.G., D'Andrea M.R., Anderson W.J., and Wang H.Y. Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 110 (2002) 199-211
22. Nordberg A. Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. Biol. Psychiatry 49 (2001) 200-210
23. Paterson D., and Nordberg A. Neuronal nicotinic receptors in the human brain. Prog. Neurobiol. 61 (2000) 75-111
24. Rees T., Hammond P.I., Soreq H., Younkin S., and Brimijoin S. Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex. Neurobiol. Aging 24 (2003) 777-787
25. Reyes A.E., Chacon M.A., Dinamarca M.C., Cerpa W., Morgan C., and Inestrosa N.C. Acetylcholinesterase-Aβeta complexes are more toxic than abeta fibrils in rat hippocampus: effect on rat beta-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss. Am. J. Pathol. 164 (2004) 2163-2174
26. Small D.H., Michaelson S., and Sberna G. Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease. Neurochem. Int. (1996) 453-483 (Review)
27. Souder E., Heithoff K., O'Sullivan P.S., Lancaster A.E., and Beck C. Identifying patterns of disruptive behavior in long-term care residents. J. Am. Geriatr. Soc. 47 (1999) 830-836
28. Soreq H., and Seidman S. Acetylcholinesterase-new roles for an old actor. Nat. Rev. Neurosci. 2 (2001) 294-302
29. Svedberg M.M., Svensson A.L., Johnson M., Lee M., Cohen O., Court J., Soreq H., Perry E., and Nordberg A. Upregulation of neuronal nicotinic receptor subunits alpha4, beta2, and alpha7 in transgenic mice overexpressing human acetylcholinesterase. J. Mol. Neurosci. 18 (2002) 211-222
30. Wang H.Y., Lee D.H., D'Andrea M.R., Peterson P.A., Shank R.P., and Reitz A.B. Beta-amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J. Biol. Chem. 275 (2000) 5626-5632